Sifting through countless of stocks in the Health Care Equipment & Supplies industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Abbott Laboratories, FUJIFILM Holdings Corporation or FUJIFILM Holdings Corporation because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

Read on to learn how Abbott Laboratories, FUJIFILM Holdings Corporation and FUJIFILM Holdings Corporation compare based on key financial metrics to determine which better meets your investment needs.

About Abbott Laboratories, FUJIFILM Holdings Corporation and FUJIFILM Holdings Corporation

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. The company also provides cancer screening and diagnostic test products. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

FUJIFILM Holdings Corporation provides products and services in the fields of healthcare, electronics, business innovation, and imaging in Japan, the Americas, Europe, Asia, and internationally. The Healthcare segment offers products and services, such as medical devices, biomedical contract development and manufacturing organization, pharmaceutical, regenerative medicine, and cosmetics and supplements in the areas of prevention, diagnosis, and treatment; equipment and materials for medical systems; drug discovery support, such as iPS cells; and cell culture media and reagents. Its Electronic segment provides display and touch panel, semiconductor and image sensors, and functional film materials; storage media and archiving services; semiconductor and display materials; industrial equipment; and fine chemicals. The Business Innovation segment offers office equipment, including multi-function devices and printers; problem-solving document services tailored to diverse business formats and roles, including system integration, cloud service, business process outsourcing, and others; equipment and materials for graphic communications; and inks and industrial inkjet printheads. Its Imaging segment provides color films, instant cameras, developing and printing systems, color papers, and photo printing services; TV and cinema lenses, surveillance cameras, industrial lenses for production line inspection, and projectors; instant photo systems; services for photofinishing; digital cameras; and optical devices. FUJIFILM Holdings Corporation was incorporated in 1934 and is headquartered in Minato, Japan.

FUJIFILM Holdings Corporation provides products and services in the fields of healthcare, electronics, business innovation, and imaging in Japan, the Americas, Europe, Asia, and internationally. The Healthcare segment offers products and services, such as medical devices, biomedical contract development and manufacturing organization, pharmaceutical, regenerative medicine, and cosmetics and supplements in the areas of prevention, diagnosis, and treatment; equipment and materials for medical systems; drug discovery support, such as iPS cells; and cell culture media and reagents. Its Electronic segment provides display and touch panel, semiconductor and image sensors, and functional film materials; storage media and archiving services; semiconductor and display materials; industrial equipment; and fine chemicals. The Business Innovation segment offers office equipment, including multi-function devices and printers; problem-solving document services tailored to diverse business formats and roles, including system integration, cloud service, business process outsourcing, and others; equipment and materials for graphic communications; and inks and industrial inkjet printheads. Its Imaging segment provides color films, instant cameras, developing and printing systems, color papers, and photo printing services; TV and cinema lenses, surveillance cameras, industrial lenses for production line inspection, and projectors; instant photo systems; services for photofinishing; digital cameras; and optical devices. FUJIFILM Holdings Corporation was incorporated in 1934 and is headquartered in Minato, Japan.

Latest Health Care Equipment & Supplies and Abbott Laboratories, FUJIFILM Holdings Corporation Stock News

As of March 27, 2026, Abbott Laboratories had a $181.1 billion market capitalization, compared to the Health Care Equipment & Supplies median of $280.1 million. Abbott Laboratories’s stock is down 17% in 2026, down 1.4% in the previous five trading days and down 17.87% in the past year.

Currently, Abbott Laboratories’s price-earnings ratio is 28.0. Abbott Laboratories’s trailing 12-month revenue is $44.3 billion with a 14.7% net profit margin. Year-over-year quarterly sales growth most recently was 4.4%. Analysts expect adjusted earnings to reach $5.473 per share for the current fiscal year. Abbott Laboratories currently has a 2.4% dividend yield.

As of March 27, 2026, FUJIFILM Holdings Corporation had a $22.7 billion market cap, putting it in the 88th percentile of all stocks. FUJIFILM Holdings Corporation’s stock is down 13.2% in 2026, up 1.7% in the previous five trading days and down 7.75% in the past year.

Currently, FUJIFILM Holdings Corporation does not have a price-earnings ratio. FUJIFILM Holdings Corporation’s trailing 12-month revenue is $22.0 billion with a 8.3% net profit margin. As of March 27, 2026, FUJIFILM Holdings Corporation has not reported significant year-over-year quarterly sales. There are no analysts providing consensus earnings estimates for the current fiscal year. FUJIFILM Holdings Corporation does not currently pay a dividend.

How We Compare Abbott Laboratories, FUJIFILM Holdings Corporation and FUJIFILM Holdings Corporation Stock Grades

Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Abbott Laboratories, FUJIFILM Holdings Corporation and FUJIFILM Holdings Corporation’s stock grades to see how they measure up against one another.

Learn more about A+ Investor here!

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

Abbott Laboratories, FUJIFILM Holdings Corporation and FUJIFILM Holdings Corporation Stock Value Grades

Company	Ticker	Value
Abbott Laboratories	ABT	D
FUJIFILM Holdings Corporation	FUJIY	na
FUJIFILM Holdings Corporation	FUJIY	na

Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection.

Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.

AAII’s A+ Investor Value Grade derives from a stock’s value score. The Value Score is the percentile rank of the average of the percentile ranks of the price-to-sales ratio, price-earnings ratio, enterprise-value-to-EBITDA (EV/EBITDA) ratio, shareholder yield, price-to-book-value ratio and price-to-free-cash-flow ratio. The score is variable, meaning it can consider all six ratios or, should any of the six ratios not be valid, the remaining ratios that are valid. To be assigned a Value Score, stocks must have a valid (non-null) ratio and corresponding ranking for at least two of the six valuation ratios.

Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are a good value and so on.

Abbott Laboratories has a Value Score of 21, which is Expensive. FUJIFILM Holdings Corporation does not have a meaningful Value Score. FUJIFILM Holdings Corporation does not have a meaningful Value Score.

The Value Stock Winner: No Clear Winner

Neither Abbott Laboratories, FUJIFILM Holdings Corporation or FUJIFILM Holdings Corporation has a high enough value grade to be considered a “winner.” Investors who are considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolio. It’s important to look at a wide range of financial metrics in order to determine if Abbott Laboratories, FUJIFILM Holdings Corporation or FUJIFILM Holdings Corporation is the better investment when it comes to value.

Abbott Laboratories, FUJIFILM Holdings Corporation and FUJIFILM Holdings Corporation Growth Grades

Company	Ticker	Growth
Abbott Laboratories	ABT	B
FUJIFILM Holdings Corporation	FUJIY	D
FUJIFILM Holdings Corporation	FUJIY	D

The foundation of growth investing is seeking out stocks of companies exhibiting strong, consistent and prolonged growth that is expected to continue into the future.

In order to compute the growth score and assign it a letter grade, the percentile ranks for each of three components‐consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations‐must be determined. These three rank figures are added together, and the sum is ranked against the entire stock universe to arrive at a company’s Growth Score to create an equal distribution of grades.

The companies in the bottom 20% of the stock universe receive Growth Grades of F, considered to be very weak, while those in the top 20% receive A grades, which are considered very strong.

Abbott Laboratories has a Growth Score of 73, which is Strong. FUJIFILM Holdings Corporation has a Growth Score of 36, which is Weak. FUJIFILM Holdings Corporation has a Growth Score of 36, which is Weak.

The Growth Grade Winner: Abbott Laboratories

As you can clearly see from the Growth Grade breakdown above, Abbott Laboratories has a more attractive growth grade than FUJIFILM Holdings Corporation. For investors who focus solely on how a company is growing relative to other companies in the same industry, Abbott Laboratories could be a good stock to add to their portfolio. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Abbott Laboratories, FUJIFILM Holdings Corporation and FUJIFILM Holdings Corporation’s Momentum Grades

Company	Ticker	Momentum
Abbott Laboratories	ABT	D
FUJIFILM Holdings Corporation	FUJIY	D
FUJIFILM Holdings Corporation	FUJIY	D

Momentum grades help to uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming. Momentum is based on the price change of a stock over a specified period relative to all other stocks.

Typically, AAII looks at the weighted relative strength over the trailing four quarters. The weighted four-quarter relative strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40% and each of the three previous quarters are given a weighting of 20%.

Abbott Laboratories has a Momentum Score of 25, which is Weak. FUJIFILM Holdings Corporation has a Momentum Score of 34, which is Weak. FUJIFILM Holdings Corporation has a Momentum Score of 34, which is Weak.

The Momentum Stock Winner: No Clear Winner

Neither Abbott Laboratories, FUJIFILM Holdings Corporation or FUJIFILM Holdings Corporation has a strong enough Momentum Grade to be considered a “winner.” Investors considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if Abbott Laboratories, FUJIFILM Holdings Corporation or FUJIFILM Holdings Corporation is the better investment when it comes to momentum.

Other Abbott Laboratories, FUJIFILM Holdings Corporation and FUJIFILM Holdings Corporation Grades

In addition to Growth, Value and Momentum, A+ Investor also provides grades for Estimate Revisions and Quality.

Earnings estimate revisions scores take into account the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, surprises beget further surprises‐or at least continued sales growth (the exact opposite is generally true, too).

AAII’s A+ Investor Quality Grade comes from the ranking of key metrics. Specifically, the quality grade is the percentile rank of the composite of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and F-Score.

These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether Abbott Laboratories, FUJIFILM Holdings Corporation and FUJIFILM Holdings Corporation pass any of our 60+ stock screens that have outperformed the market since their creation.

So, Which Is the Better Investment, Abbott Laboratories, FUJIFILM Holdings Corporation or FUJIFILM Holdings Corporation Stock?

Overall, Abbott Laboratories stock has a Value Score of 21, Growth Score of 73 and Momentum Score of 25.

FUJIFILM Holdings Corporation stock has a Value Score of , Growth Score of 36 and Momentum Score of 34.

FUJIFILM Holdings Corporation stock has a Value Score of , Growth Score of 36 and Momentum Score of 34.

Comparing Abbott Laboratories, FUJIFILM Holdings Corporation and FUJIFILM Holdings Corporation’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.

Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.

A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.